3-D Matrix, Common Stock

The latest common stock for DMTRF is $17B as of July 2026. That compares with $16B in the prior-year period — up 7.4% year over year. Investors often review this figure alongside 3-D Matrix,'s historical trend and sector peers before judging valuation or financial health.

Over the past year, DMTRF's common stock moved from $16B to $17B — a 7.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in 3-D Matrix,'s operating scale or balance-sheet position.

A common stock figure of $17B for DMTRF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting DMTRF's common stock ($17B), review year-over-year change from $16B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack 3-D Matrix,'s common stock against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.